Foresight Autonomous (FRSX): supplier relationships, corporate action, and what investors should price in

Foresight Autonomous Holdings Ltd (FRSX) designs and sells 3D perception sensor systems and vehicle-safety software to automotive OEMs and transport operators, monetizing through product sales, software integrations and public-private trials that validate its Eye-Net collision-prevention stack. The company is a micro‑cap, loss-making technology supplier with modest trailing revenue and operating losses, and its principal value drivers are commercial validation with Tier‑1 partners and platform integrations that scale into recurring software and licensing revenue.
Explore the supplier profile at https://nullexposure.com/ for structured supplier-risk signals and primary-source tracking.

How Foresight operates as a supplier and what that means for counterparties

Foresight’s operating model is partnership-driven rather than volume OEM supply today: the company pursues live trials and integrations (software development kits, platform integrations) to convert proofs-of-concept into production programs. Contracting posture is collaborative and trial-oriented, relying on multi‑party pilots (carriers, telcos, transport authorities) to build references that enable commercial scale.

Concentration and maturity are material constraints to underwriting Foresight as a supplier: market capitalization (~$7.8M) and trailing revenue (~$452k) reflect an early-stage supplier with substantial operating losses (EBITDA ≈ -$12.55M). Counterparty criticality is asymmetric: Foresight benefits greatly from endorsing partners (e.g., OEMs, NVIDIA, Orange) for technology credibility, but those partners are not materially dependent on Foresight for their core businesses. Governance and liquidity signals are affected by recent corporate housekeeping: the company executed an ADS ratio change that changes share fungibility and custody flows—this is an operational detail counterparties must factor into settlement, custody and investor relations workflows.

If you are evaluating counterparty risk or supplier concentration in an auto-perception program, track these disclosures systematically at https://nullexposure.com/ to see how corporate actions and partner integrations alter operational risk and liquidity.

Relationships and recent disclosures — line by line

Below are the relationships extracted from public coverage and their plain-English summaries, each followed by a source reference.

The Bank of New York Mellon (Depositary Bank) — Foresight implemented an ADS ratio change effective February 26, 2026, requiring certified ADS holders to surrender existing ADSs to BNY Mellon for cancellation and receive one new ADS for every three old ADSs. Source: InvestingNews press release (FY2026).
Nasdaq (Nasdaq Capital Market) — Foresight’s ADSs will continue trading on Nasdaq under the symbol “FRSX” after the ADS ratio change, with a new CUSIP assigned as part of the corporate action. Source: InvestingNews press release (FY2026).
NVIDIA — Foresight integrated NVIDIA’s Jetson Orin computing platforms into its 3D perception technologies, indicating an edge compute partnership for in-vehicle perception processing. Source: TheRobotReport article (FY2025).
Nasdaq (duplicate mention) — Bitget coverage reiterated that the ADSs will keep trading under “FRSX” on Nasdaq with a new CUSIP following the ratio change. Source: Bitget news (FY2026).
The Bank of New York Mellon (duplicate mention) — Bitget also summarized the mandatory surrender and exchange process for certified ADS holders being handled by BNY Mellon as depositary bank. Source: Bitget news (FY2026).
Atos SE — In a Bordeaux V2X collision-prevention live trial, Atos’ app was listed among the platforms integrating Eye‑Net’s SDK, highlighting Atos as a participating systems integrator in the public-transport trial. Source: QuiverQuant coverage of the trial announcement (FY2026).
Orange S.A. — Orange provided a mobile app platform integrated with Eye‑Net’s collision-alert system during the large-scale live public-transportation safety trial in Bordeaux. Source: QuiverQuant (FY2026) and InvestingNews (FY2025).
The Depository Trust Company (DTC) — Holders of uncertificated ADSs in DTC and in Direct Registration System (DRS) will have their ADSs automatically exchanged as part of the ADS ratio conversion and need not take action. Source: InvestingNews press release (FY2026).
Keolis Bordeaux Métropole Mobilités — Keolis’ TBM app for cyclists participated in the Bordeaux live trial integrating Eye‑Net’s SDK, demonstrating municipal transit operator engagement. Source: QuiverQuant coverage (FY2026).
MS-IR LLC — MS-IR LLC is listed as the investor relations contact in Foresight communications, signaling the retained IR advisor for corporate disclosures and investor outreach. Source: InvestingNews announcement (FY2025 & FY2026).
TASE (Tel Aviv Stock Exchange) — Foresight announced the ADS ratio change in a filing that referenced its dual listing (Nasdaq and TASE), confirming the company’s cross-market listing posture. Source: InvestingNews press release referencing TASE (FY2026).
The Depository Trust Company (duplicate mention) — Bitget coverage repeated that DTC and DRS holdings will be automatically exchanged in the ratio conversion process. Source: Bitget news (FY2026).
Orange S.A. (duplicate mention from InvestingNews) — InvestingNews described the live trial using Orange’s mobile app platform integrated with Eye‑Net’s collision alert system alongside Renault, Allianz and others. Source: InvestingNews trial announcement (FY2025).

Constraints and company-level signals

There are no constraints flagged in the available relationship feed for FRSX. That absence is itself a corporate-level signal: no explicit contractual or regulatory encumbrances were returned by the supplier-relationship processor, so counterparties should infer that there are no recorded covenant, exclusivity, or procurement constraints in the feed. Operationally, Foresight’s supplier posture is dominated by pilot-stage commercial relationships and custody actions (ADS ratio change), not by long-term supply contracts reflected in the public results.

Investment implications — what to underwrite and what to stress-test

Commerciality vs. credibility: Partnerships with NVIDIA, Orange, Atos and participation in high‑profile trials provide technology endorsement that is essential for converting pilots into orders, but do not guarantee volume production. Underwrite conversion risk and timeline rigorously.
Liquidity and capital structure: The ADS ratio change and micro‑cap capitalization (~$7.8M) affect trading liquidity and could compress free-float availability; custodial workflows (BNY Mellon, DTC) must be monitored around corporate actions. Treat custodial and registry details as operational risk for execution.
Financial fragility: Trailing revenue (~~$452k) against negative EBITDA (~~-$12.55M) creates a runway and financing sensitivity risk. Stress-test partner payments, milestone receipts and dilution scenarios.
Concentration of signaling partners: High‑visibility partners are valuable for sales pipeline validation, but dependence on trials and SDK integrations makes contract enforceability and commercial terms (SaaS vs. one-off sale) critical negotiation points.

For deeper supplier-risk due diligence and a timeline of disclosures, consult the structured supplier profile hub at https://nullexposure.com/.

Bottom line and action items

Foresight is a technology-first, pilot-led automotive perception supplier with important platform partnerships and a recent ADS ratio restructuring that affects custody and trading. Investors and operators should price in high conversion risk, low liquidity, and operational exposure to partner trials while valuing the credibility uplift from integrations with NVIDIA, Orange and municipal transit pilots. For sourced, monitored tracking of counterparties and corporate actions, visit https://nullexposure.com/ and review the supplier dossier before committing capital or operational integration resources.